Several studies have demonstrated that mutations in FERMT3 can lead to leukocyte adhesion deficiency syndrome type 3 (LAD3), resulting in defective platelet function and immunodeficiency [26,27,28]. Here, FERMT3 is linked to leukocyte adhesion deficiency 3.